Polyurethane Foam Allergy: Flame Retardants in Mattresses Are the Real Story
Polyurethane foam is made from polyols and diisocyanates; fully cured consumer-grade PU foam rarely causes contact dermatitis. Only 0.8% of dermatology patients reacted to TDI in patch testing. The real concern is flame retardants — TDCPP chlorinated Tris, banned from children's pajamas in 1977 for mutagenicity, was detected in 85% of US couches. California's TB 117-2013 revision eliminated mandatory open-flame testing, enabling FR-free foam options. CertiPUR-US certification is the consumer safety benchmark for mattresses and furniture foam.
Free · 5 min · Insurance accepted
Key facts
Only 0.8% of dermatology patients reacted to TDI in patch testing — fully cured consumer-grade PU foam rarely causes contact dermatitis.
TDCPP (chlorinated Tris) flame retardant — banned from children's pajamas in 1977 for mutagenicity — was detected in 85% of US couches in surveillance studies.
California TB 117-2013 (effective January 2015) eliminated mandatory open-flame testing for furniture foam, making FR-free foam furniture legally manufacturable for the first time.
CertiPUR-US certification prohibits TDCPP, TCEP, PBDEs, and other harmful flame retardants — it is the primary consumer benchmark for evaluating mattress foam safety.
What Is Polyurethane Foam Allergy?
Polyurethane foam is synthesized by reacting polyols with diisocyanates — primarily toluene diisocyanate (TDI) or methylene diphenyl diisocyanate (MDI) — to produce the resilient, flexible foam used in mattresses, furniture cushions, carpet padding, and upholstered products throughout American homes.
When the reaction is complete and the foam is fully cured, the residual isocyanate content in consumer products is extremely low, and clinical contact dermatitis from cured PU foam is uncommon. A landmark study by Kanerva et al. (1999) found that only 0.8% of 360 dermatology patients reacted to TDI patch testing — a strikingly low figure for a material covering nearly every household sleeping surface.
What patients searching 'polyurethane allergy' are more likely to be concerned about — and with good reason — is the flame retardant chemistry added to PU foam. Flame retardants are mixed into mattress and furniture foam to meet flammability standards and are not part of the polyurethane polymer itself. Some of the historically dominant flame retardants, particularly TDCPP (chlorinated Tris), are now recognized carcinogens and endocrine disruptors that were found in 85% of US couches in surveillance studies.
This page is distinct from the laminated fabric page, which covers PU adhesives in bonded textile products, and from the rubber page, which covers natural latex and synthetic rubber allergens. PU foam has no latex proteins; reactions in patients with both PU foam and latex sensitivity require separate evaluation of each exposure.
The critical consumer question for most people is not 'am I allergic to PU foam?' but rather 'does my mattress contain harmful flame retardants?' — and the answer to that question has been shaped decisively by California's 2013 regulatory turning point.
Symptoms Associated With Polyurethane Foam Exposure
Recognizing symptoms early helps you get the right treatment faster.
Occupational isocyanate contact dermatitis
moderateEczematous rash on hands, forearms, and exposed skin in foam manufacturing workers handling uncured TDI or MDI-containing materials.
Occupational isocyanate asthma
severeCough, wheeze, chest tightness, and shortness of breath in foam production workers, typically worse on workdays and improving on weekends or vacation.
Consumer contact dermatitis (rare)
mildMild localized rash at direct foam contact areas in the rare consumer sensitized to residual isocyanates in cured foam products.
Skin irritation from new foam
mildMild transient skin irritation or redness at contact sites with new foam products, attributable to volatile organic compounds outgassing in the first days after purchase.
Respiratory irritation (outgassing)
mildThroat or nasal irritation from volatile organic compound outgassing of new foam mattresses or furniture, typically resolving with aeration over days to weeks.
Eye irritation
mildWatery, irritated eyes in rooms with new foam products outgassing VOCs, typically transient and resolving with ventilation.
When to see a doctor
The symptom spectrum associated with PU foam exposure spans two different mechanisms: contact dermatitis from residual isocyanates (rare in consumers, significant in occupational settings), and systemic health concerns from flame retardant chemical exposure (not a classic allergy, but a toxicological concern relevant to long-term mattress and furniture safety). Contact dermatitis from PU foam, when it does occur, is typically occupational. Workers handling uncured foam report eczematous rash on exposed skin, particularly hands and forearms. Sensitized workers can develop dermatitis even from low-level isocyanate skin contact after sensitization is established. In the rare consumer who reacts to fully cured foam, the reaction is typically mild and localized to direct contact skin. Occupational asthma from isocyanate sensitization deserves special attention. TDI and MDI are among the most common causes of occupational asthma worldwide, and workers who develop isocyanate respiratory sensitization may react at concentrations far below occupational exposure limits. Symptoms include cough, wheezing, chest tightness, and shortness of breath, typically worse at work and improving on days away from the factory. For consumers, the symptoms most practically associated with flame retardant exposure are not immediate allergic reactions but rather the concerns identified in population studies: endocrine disruption markers, reproductive effects, and potential carcinogenicity with long-term exposure. These are regulatory and toxicological concerns rather than clinical allergy presentations. Seek emergency care if you develop breathing difficulty, throat swelling, or widespread hives after contact with any foam product — while unlikely from PU foam specifically, these symptoms indicate a severe allergic reaction requiring immediate attention.
Polyurethane Foam and Respiratory Disease
Occupational isocyanate asthma is one of the most clinically significant respiratory outcomes associated with PU foam chemistry. TDI and MDI, the diisocyanate precursors used in foam synthesis, are among the most potent occupational respiratory sensitizers identified. Workers in foam manufacturing who are sensitized to isocyanates can develop progressive occupational asthma that worsens with each workplace exposure and eventually limits their ability to work in any isocyanate-containing environment. For consumers using finished, cured PU foam products, the isocyanate asthma risk is negligible — fully reacted polyurethane contains no free isocyanate groups capable of sensitizing the airways at consumer exposure levels. Flame retardant chemicals in foam (TDCPP, PBDEs) are not established asthma inducers through a proven IgE mechanism, though some animal and epidemiological studies have suggested associations between PBDE exposure and respiratory outcomes. These remain areas of ongoing research rather than established clinical pathways. Patients with pre-existing asthma who sleep on foam mattresses and notice increased nocturnal symptoms should consider whether dust mites — which colonize foam mattresses abundantly — are a more plausible trigger than the foam chemistry itself. Dust mite allergy is a far more common cause of mattress-associated asthma symptoms than PU foam chemistry.
Health Concerns Beyond Contact Dermatitis
For PU foam, the clinically important complications are less about contact dermatitis and more about the long-term toxicological implications of flame retardant exposure, particularly for occupational and infant populations. Occupational complications of isocyanate sensitization are significant. Once sensitized, workers may develop symptoms at isocyanate concentrations far below permissible exposure limits, effectively ending their ability to work in foam manufacturing, painting, spray-coating, or any other isocyanate-handling occupation. The natural history of occupational isocyanate asthma is variable — some workers improve after leaving the exposure, but others develop persistent asthma that continues even without ongoing isocyanate contact. For consumers, the reproductive and endocrine effects associated with TDCPP exposure — including decreased semen quality documented by Stapleton et al. (2014) — represent health concerns for adults sleeping on treated foam nightly over years. The carcinogenicity concern (California Proposition 65 listing for TDCPP) applies to long-term cumulative exposure. Infants and children, with higher metabolic rates and proportionally greater skin-surface-to-body-mass ratios, absorb higher relative doses from the same mattress. CertiPUR-US certification and California TB 117-2013 compliant products represent the practical consumer-level mitigation of these concerns.
Occupational asthma (isocyanate)
Foam manufacturing workers sensitized to TDI or MDI can develop progressive asthma that persists even after leaving isocyanate-exposed work environments.
Endocrine disruption from flame retardants
Long-term systemic absorption of TDCPP from foam products has been associated with endocrine disruption and decreased semen quality in occupational and environmental studies.
Carcinogen exposure (TDCPP)
TDCPP is listed as a California Proposition 65 carcinogen; daily sleeping contact with treated mattresses represents ongoing low-level exposure.
Infant developmental concerns
Infants spending many hours on foam mattresses have proportionally higher exposure to any outgassed flame retardant compounds given their smaller body mass and higher respiratory rates.
What Causes Reactions to Polyurethane Foam?
Reactions attributable to polyurethane foam products arise from two distinct sources: residual isocyanate compounds from incomplete curing, and flame retardant chemicals added to meet flammability regulations. Understanding which mechanism applies guides the appropriate diagnostic and management approach.
How it works
Occupational isocyanate sensitization follows a mixed mechanism: respiratory sensitization to airborne TDI or MDI occurs through an incompletely understood pathway that may involve both IgE-mediated and non-IgE-mediated components, producing occupational asthma. Contact dermatitis from isocyanate skin exposure follows Type IV delayed hypersensitivity, with T-cell recognition of isocyanate-protein conjugates at the dermal exposure site. Flame retardant chemicals like TDCPP are not established contact allergens in consumer settings; their toxicological concerns are primarily endocrine disruption and carcinogenicity from systemic absorption over time rather than immediate immune-mediated reactions.
Residual isocyanates (TDI and MDI) in uncured or incompletely cured PU foam can cause occupational sensitization in manufacturing workers, producing both respiratory disease and allergic contact dermatitis. In finished consumer products — a mattress or sofa cushion — the foam is fully cured and residual isocyanate levels are low. Kanerva et al.'s 1999 finding of only 0.8% TDI patch-test positivity in dermatology patients reflects this low consumer exposure level.
Flame retardants represent the larger health concern for consumers. PBDEs (polybrominated diphenyl ethers) dominated PU foam flame retardancy until phase-out in 2005. A 2012 study by Stapleton et al. in Environmental Science and Technology found PBDEs in 39% of pre-2005 furniture foam. When PBDEs were phased out, they were largely replaced by TDCPP ('chlorinated Tris'), which had ironically been banned from children's pajamas in 1977 due to mutagenicity findings. TDCPP is a California Proposition 65 carcinogen and an endocrine disruptor — a 2014 study by Stapleton et al. in Current Opinion in Pharmacology associated it with decreased semen quality in furniture workers. FR chemicals were detected in 85% of US couches in environmental surveillance data.
The regulatory turning point came in 2013 when California revised its Technical Bulletin 117 (TB 117-2013), eliminating the open-flame ignition test that had required chemical flame retardants in foam since 1975. This change enabled manufacturers to produce FR-free foam products that pass newer smolder resistance tests without TDCPP or PBDEs.
Risk factors to watch for
Occupational PU foam manufacturing
Workers in foam production facilities with exposure to uncured TDI or MDI vapors are at significant risk for occupational asthma and isocyanate contact dermatitis.
Pre-2013 furniture or mattresses
Sofas and mattresses manufactured before California's TB 117-2013 revision are more likely to contain TDCPP, PBDEs, or other flame retardants at significant concentrations.
Non-CertiPUR-US certified foam products
Mattresses and cushions without CertiPUR-US certification have not been independently tested for prohibited flame retardants, heavy metals, or VOC emissions.
Atopic dermatitis
Patients with impaired skin barrier absorb chemicals from mattress materials at higher rates, including any residual flame retardant compounds that outgas from foam.
Infant and young child exposure
Infants and young children spending prolonged periods on foam mattresses have proportionally higher body burden of any outgassed flame retardant compounds given their smaller body size and higher respiratory rate.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Polyurethane Foam Contact Allergy
For patients with suspected contact dermatitis from PU foam products — particularly occupational workers — patch testing is the appropriate diagnostic approach. TDI 0.1% pet. and MDI patch test preparations are available and can be applied by a board-certified dermatologist or occupational medicine physician. Readings at 48 hours and 96 hours are standard; isocyanate reactions may sometimes require reading at day 7 for delayed positive responses. For healthcare workers with occupational isocyanate asthma, spirometry and specific inhalation challenge tests (isocyanate challenge under controlled conditions) are the diagnostic tools of choice, conducted by occupational medicine specialists or pulmonologists. For consumers who are concerned about flame retardant exposure from their existing mattress, third-party laboratory testing of foam samples (XRF analysis for bromine, GC-MS for specific FR compounds) is available through certified environmental testing laboratories. This is a chemical safety question, not a clinical allergy question, and does not require patch testing. For patients wanting to evaluate coexisting IgE-mediated allergies — dust mites, pet dander, pollen — at-home allergy testing services such as Curex provide panels covering 40+ common allergens with results in approximately 5 days, often with insurance coverage. If nocturnal sneezing, congestion, or asthma symptoms correlate with mattress use, dust mite IgE is a far more likely diagnosis than PU foam contact allergy. IgE testing for 'foam allergy' is not an established diagnostic procedure — PU foam contact allergy is Type IV if it occurs at all, and IgE blood tests will not detect it.
Patch Test (TDI/MDI series)
TDI 0.1% pet. and MDI applied to upper back for 48 hours with readings at 48h, 96h, and optionally day 7 for delayed reactions. Appropriate for workers with occupational PU foam exposure.
Specific Inhalation Challenge (SIC)
Controlled inhalation of dilute isocyanate vapor under medical supervision with spirometry monitoring; the definitive test for occupational isocyanate asthma.
Dust Mite Specific IgE Testing
Blood test for IgE antibodies to Der p 1 and Der f 1 dust mite allergens in patients with nocturnal respiratory or skin symptoms associated with mattress contact.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreatment for Polyurethane Foam Reactions
See how different approaches stack up for managing your allergy symptoms long-term.
Treatment strategy depends on whether the clinical problem is occupational contact dermatitis from isocyanates, occupational asthma from isocyanate inhalation, or consumer concern about flame retardant exposure.
For occupational isocyanate contact dermatitis, management follows the standard ACD pathway: patch testing to confirm isocyanate sensitization, notification of the employer for workplace controls and possible relocation from isocyanate-exposure tasks, topical corticosteroids for active dermatitis, and barrier cream use during unavoidable exposures.
For occupational isocyanate asthma, the guiding principle is removal from isocyanate exposure — even partial exposure reduction may not prevent progression. Workers with confirmed isocyanate asthma should be evaluated for permanent occupational reassignment. Bronchodilators and inhaled corticosteroids manage acute bronchospasm, but do not address the sensitization.
For consumer flame retardant concerns, the actionable step is replacing non-CertiPUR-US foam products with certified alternatives. New purchases should carry the CertiPUR-US certification, which prohibits PBDEs, TDCPP, TCEP, TDBPP, and TEPA; regulates phthalates per CPSC limits; restricts heavy metals; and caps VOC emissions at less than 0.5 ppm. Note that CertiPUR-US certifies the foam core but does not certify latex foam or the complete finished mattress.
Occupational avoidance (isocyanate workers)
For sensitized workers, removal from isocyanate-exposure tasks is the primary management. Complete elimination of exposure is the goal; partial exposure reduction typically does not prevent disease progression.
Essential for confirmed occupational sensitization; does not reverse established sensitization.
CertiPUR-US certified foam replacement
Replacing flame-retardant-containing foam mattresses and cushions with CertiPUR-US certified FR-free alternatives is the primary consumer intervention.
Eliminates ongoing TDCPP and PBDE exposure for the consumer; direct reduction in long-term flame retardant body burden.
Topical corticosteroids
For active isocyanate contact dermatitis, topical steroids reduce inflammation and itch at affected skin sites.
Hydrocortisone 1% (OTC), triamcinolone acetonide 0.1%, clobetasol 0.05% (prescription)
High for symptom control; does not address the underlying isocyanate sensitization.
Inhaled bronchodilators
Short-acting beta-agonists provide bronchospasm relief for isocyanate-induced occupational asthma during exposure or acute episodes.
Albuterol (Ventolin, ProAir)
Effective for acute bronchospasm; does not address sensitization.
Mattress encasement
Allergen-impermeable encasements reduce dust mite exposure from foam mattresses and provide a physical barrier between sleeping skin and any outgassing foam chemicals.
High for dust mite reduction; partial barrier for chemical outgassing.
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy Context for Polyurethane Foam Reactions
Instead of masking symptoms, immunotherapy retrains your immune system.
For the contact dermatitis and occupational asthma forms of PU foam reaction — both of which involve non-IgE immune mechanisms — conventional allergen immunotherapy is not an established treatment option. Isocyanate contact sensitization (Type IV) cannot be desensitized with allergy shots or sublingual drops. Occupational isocyanate asthma, which involves a mixed immune mechanism, is managed primarily through exposure elimination rather than immunotherapy. Patients searching 'polyurethane foam allergy treatment' who have nocturnal respiratory symptoms, sneezing, or perennial nasal congestion associated with their mattress are more likely dealing with dust mite allergy than PU foam allergy. Dust mites colonize foam mattresses abundantly and are one of the most common causes of year-round indoor allergy symptoms. If you have IgE-mediated respiratory allergies — hay fever, dust mite asthma, or pet dander sensitivity — sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), can address those conditions with a treatment taken at home rather than through weekly clinic injections. A real-world Curex study of 2,897 patients on at-home sublingual immunotherapy, published in Frontiers in Allergy in 2026, found that clinically meaningful symptom improvement rose to 45% of patients by two years and quality-of-life improvement reached 90.7%, with adherence over 90% and no anaphylaxis reported. For occupational workers seeking guidance on all their workplace-related health concerns, an occupational medicine physician with experience in isocyanate sensitization is the appropriate specialist referral.
Determine the clinical question
Are you an occupational foam worker with contact dermatitis or asthma? Or a consumer concerned about flame retardants? The management pathways are different.
For workers: patch test and spirometry
Occupational medicine evaluation with isocyanate patch testing and spirometry determines whether sensitization has occurred and guides exposure management.
For consumers: check for CertiPUR-US
Look for the CertiPUR-US seal on mattress and furniture foam products to ensure prohibited flame retardants are absent.
Evaluate dust mites if respiratory symptoms are present
Dust mite IgE testing is appropriate for mattress-associated nocturnal respiratory or skin symptoms — far more common than PU foam sensitization.
“Complete FR exposure elimination with CertiPUR-US certified products effectively addresses the primary consumer chemical concern; occupational isocyanate asthma outcomes depend on timing of exposure cessation.”
Not sure if your mattress or something else is the cause?
An at-home allergy test can help confirm whether dust mites, not foam, are really behind your symptoms.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Polyurethane Foam Concerns
For the majority of consumers, managing PU foam concerns is primarily a product selection and replacement project rather than an ongoing medical management challenge. Once a CertiPUR-US certified mattress is in use, the daily FR exposure from that source is largely eliminated. For occupational workers who have developed isocyanate sensitization, the challenge is larger: job modification, PPE compliance, and potentially career transition away from isocyanate-exposure industries. Occupational health support from employers and occupational medicine physicians is the appropriate resource. Documentation of isocyanate sensitization in occupational health records is important for workers' compensation claims if occupational asthma develops. For patients who have both PU foam concerns and known dust mite allergy, mattress encasements — combined with regular washing of bedding in hot water — address the dust mite allergen most effectively while the CertiPUR-US certification addresses the chemical concern. These two interventions are not in conflict and can be implemented simultaneously.
Mattress certification checklist
When purchasing a mattress, look for CertiPUR-US on the product label or tag. The certification database at certipurus.com allows verification of specific product certifications before purchase.
Occupational documentation
Workers with isocyanate sensitization should maintain copies of their patch test results and spirometry findings in personal health records, and ensure occupational health records reflect the diagnosis for workplace accommodation and workers' compensation purposes.
Infant sleep surface priority
Replace infant mattresses in cribs and play yards with CertiPUR-US certified alternatives. Infants' proportionally higher dermal and respiratory exposure to outgassed foam chemicals makes this the highest-priority replacement item for households with young children.
When Do Polyurethane Foam Reactions Occur?
Polyurethane foam represents a year-round exposure for the majority of Americans who sleep on foam mattresses and sit on foam-cushioned furniture daily. Unlike seasonal allergens that fluctuate with pollen calendars, PU foam is a constant indoor exposure source. Flame retardant outgassing from foam products is generally higher in warm weather, when elevated indoor temperatures increase the volatilization rate of semi-volatile organic compounds. Summer months, combined with closed windows and air conditioning, can concentrate volatile flame retardant compounds in bedroom air. Infants sleeping in heated nurseries with new foam mattresses represent the highest-exposure-density scenario from this mechanism. Occupational isocyanate exposure is year-round for foam manufacturing workers, with spikes during periods of heavy production output. Factory workers with occupational asthma often notice their symptoms correlate with production schedule rather than season. New foam products may outgas at higher initial rates than older, off-gassed items — patients who notice new symptoms after purchasing a new mattress or sofa should consider off-gassing period of several weeks with maximum ventilation before regular use.
January - December
medium intensity
June - August
high intensity
Preventing Polyurethane Foam Health Concerns
Prevention of PU foam health concerns centers on product selection at the point of purchase, particularly for the large-surface, long-contact items that define daily foam exposure: mattresses, sofa cushions, and infant products. The CertiPUR-US certification is the primary consumer tool for foam safety. CertiPUR-US prohibits PBDEs, TDCPP (chlorinated Tris), TCEP, TDBPP, and TEPA; regulates phthalates according to CPSC consumer product limits; bans regulated heavy metals; and caps total VOC emissions at less than 0.5 ppm. Products bearing the CertiPUR-US seal have been tested by an independent laboratory. Note that certification covers the foam core only — it does not apply to latex foam or to the entire finished mattress including cover and coils. For new foam products, airing them out in a well-ventilated space or outdoors for one to two weeks before use reduces the initial VOC outgassing concentration. This is particularly important for nursery mattresses where infants will spend many hours. For occupational workers in foam manufacturing, personal protective equipment (respirators rated for isocyanate vapors), engineering controls (local exhaust ventilation), and pre-employment and periodic isocyanate sensitization monitoring are the prevention cornerstones.
Choose CertiPUR-US certified foam
Look for the CertiPUR-US seal on mattresses and furniture cushions — it prohibits TDCPP, PBDEs, and other harmful flame retardants and caps VOC emissions at safe levels.
Air out new foam products
Place new mattresses, cushions, or foam products in a well-ventilated area for one to two weeks before regular use to allow initial off-gassing to dissipate.
Prioritize certifications for infant sleep surfaces
Infant mattresses should carry CertiPUR-US certification; infants spend up to 16 hours daily on sleep surfaces and have higher relative exposure to any outgassed chemicals.
Occupational PPE for foam workers
Workers handling uncured PU foam should use NIOSH-approved isocyanate respirators, chemical-resistant gloves, and protective clothing to prevent sensitization.
Use allergen-proof mattress encasements
Impermeable mattress encasements reduce dust mite exposure (the more common mattress allergen) and provide a physical barrier over foam surfaces.
Prognosis for Polyurethane Foam Reactions
For consumers with mild contact dermatitis from cured PU foam — a relatively uncommon presentation — prognosis is excellent with avoidance. For occupational workers with isocyanate sensitization, prognosis depends on the timing of exposure cessation. Workers who leave isocyanate-exposure jobs early, before sensitization progresses to fixed occupational asthma, have better long-term respiratory outcomes than those who continue working through symptomatic asthma for years. For the broader population concerned about flame retardant exposure from existing foam products, the practical news is positive: the regulatory trajectory since 2013 has been toward FR-free products, and the market has responded. A growing number of mattresses and furniture products are manufactured with FR-free foam and carry independent safety certifications. Replacing an old untested mattress with a CertiPUR-US certified alternative is a concrete, impactful, and permanent reduction in household FR exposure.
Key takeaways
Consumer contact dermatitis from fully cured PU foam is uncommon — only 0.8% of patch-tested patients react to TDI.
Flame retardants — particularly TDCPP — found in 85% of US couches are the more significant health concern than the foam polymer itself.
California TB 117-2013 (2013) eliminated mandatory open-flame testing, enabling FR-free foam products.
CertiPUR-US certification prohibits TDCPP, PBDEs, and other harmful flame retardants and is the key consumer safety signal.
Dust mites, not PU foam chemistry, are the most common cause of mattress-associated allergy symptoms.
Most reactions attributed to mattress or couch foam are driven by flame retardants mixed into the foam, not the polyurethane polymer itself — CertiPUR-US certification and FR-free labeling are the meaningful indicators to look for when advising chemically sensitive patients on furniture choices.
Frequently Asked Questions
True allergic contact dermatitis from fully set, finished polyurethane foam in consumer mattresses is uncommon — patch-test studies have found only a small share of dermatology patients react to the key isocyanate chemistry, reflecting the low residual content in finished foam. Dust mite allergy is a far more common cause of mattress-associated symptoms — mites colonize foam mattresses abundantly and are among the most prevalent indoor allergens. If you experience sneezing, congestion, or skin reactions consistently associated with your mattress, dust mite IgE testing is the appropriate first evaluation, not foam patch testing.
Medical References
- [1]Kanerva L, et al. Patch testing with rubber chemicals: review of materials and methods. Contact Dermatitis. 1999;40(4):181-188.
- [2]Stapleton HM, et al. Identification of flame retardants in polyurethane foam collected from baby products. Environmental Science & Technology. 2012;45(12):5323-5331.
- [3]Stapleton HM, et al. Novel and high volume use flame retardants in US couches reflective of the 2005 PentaBDE phase out. Current Opinion in Pharmacology. 2014;19:125-133.
- [4]California Bureau of Home Furnishings and Thermal Insulation. Technical Bulletin 117-2013: Requirements, Test Procedure and Apparatus for Testing the Smolder Resistance of Materials Used in Upholstered Furniture. 2013.
- [5]CertiPUR-US. Certification Program Standards. Available at: certipurus.com.
- [6]Isufi I, et al. Temporal trends in rubber accelerator contact allergy: a meta-analysis of 826,543 patients across 106 studies. Contact Dermatitis. 2025.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Polyurethane Foam allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.